| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |